| JYHB2000688 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2020-06-02 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Filed | 2020-06-09 | view |
| JYHB0700572 | TMC278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2007-05-24 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2007-11-15 | view |
| JYHB1901124 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2019-09-25 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2019-12-05 | view |
| JYHB2000892 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2020-07-03 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Approval Completed-Pending Certificated | 2021-09-22 | view |
| JYHB0700573 | TMC278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2007-05-24 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2007-11-15 | view |
| JYHB1801114 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2018-09-17 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2021-01-04 | view |
| JYHB2001015 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2020-06-29 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Filed | 2020-07-01 | view |
| JXHB0600006 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2006-03-06 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2006-08-03 | view |
| J0401973 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs(1.1) | Import Drug Application | 2004-10-25 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2005-03-30 | view |
| JXHB0600008 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2006-03-06 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2006-08-03 | view |
| J0401975 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs(1.1) | Import Drug Application | 2004-10-25 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2005-03-30 | view |
| JXHB0600007 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2006-03-06 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2006-08-03 | view |
| J0401974 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs(1.1) | Import Drug Application | 2004-10-25 | 杨森制药有限公司 | Johnson & Johnson Innovative Medicine | Certificate Issued | 2005-03-30 | view |
| JXHL1100299 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Import Drug Application | 2011-09-01 | Tibotec, Inc. | Tibotec Inc | Certificate Issued | 2013-01-21 | view |
| JXHB0500036 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2005-10-21 | Tibotec Pharmaceuticals Limited | Tibotec Pharmaceutical Co Ltd | Certificate Issued | 2006-12-08 | view |
| JXHB0500035 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2005-10-21 | Tibotec Pharmaceuticals Limited | Tibotec Pharmaceutical Co Ltd | Certificate Issued | 2006-12-08 | view |
| JXHB0500034 | TMC 278 | rilpivirine | Active ingredient | Chemical Drugs | Supplementary Application | 2005-10-21 | Tibotec Pharmaceuticals Limited | Tibotec Pharmaceutical Co Ltd | Certificate Issued | 2006-12-08 | view |
| JYHZ1700005 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | License Renew | 2017-06-26 | Janssen-Cilag International N.V. | Janssen-Cilag International NV | Certificate Issued | 2017-11-21 | view |
| JYHB1600462 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2016-04-07 | Janssen-Cilag International N.V. | Janssen-Cilag International NV | Certificate Issued | 2016-12-22 | view |
| JYHB1501367 | 利匹韦林片 | rilpivirine | Tablet | Chemical Drugs | Supplementary Application | 2015-10-21 | Janssen-Cilag International N.V. | Janssen-Cilag International NV | Certificate Issued | 2016-09-26 | view |
